|
|
|
|
| LEADER |
00000nab a2200000 a 4500 |
| 001 |
vtls008415755 |
| 003 |
SK-MaSNL |
| 005 |
20260304150406.0 |
| 008 |
250505c2005 xo 0 slo |
| 015 |
|
|
|a SNBCL2005/5
|
| 035 |
|
|
|a SLK033408
|
| 035 |
|
|
|a urn:nbn:sk:snk-ab337o
|
| 035 |
|
|
|a (urnnbn)urn:nbn:sk:snk:ar-a05run
|
| 035 |
|
|
|a (uuid)d1dfabad-8023-47a1-b700-8f6c28c6b010
|
| 040 |
|
|
|a SNKBUCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
0 |
|
|a eng
|
| 044 |
|
|
|a xo
|c SK
|
| 080 |
|
|
|a 616.153.915:615.272.4:061.3
|2 1981
|
| 100 |
1 |
|
|a Pella, Daniel,
|d 1962-
|4 aut
|9 20720
|
| 245 |
1 |
0 |
|a Treatment to target - comparison of statins efficacy and safety
|c D. Pella, R. Rybar, V. Vargova
|
| 650 |
0 |
7 |
|a hyperlipémia
|x diagnostika
|2 MESH
|9 1236340
|
| 650 |
0 |
7 |
|a lipoproteíny, LDL-cholesterol
|x účinky nežiadúce
|2 MESH
|9 1428283
|
| 650 |
0 |
7 |
|a inhibítory hydroxymetylglutaryl-CoA-reduktázy
|x aplikácia a dávkovanie
|2 MESH
|9 1074806
|
| 650 |
0 |
7 |
|a štúdie cross-over
|2 MESH
|9 1440357
|
| 650 |
0 |
7 |
|a abstrakty z kongresu
|2 MESH
|9 168204
|
| 700 |
1 |
|
|a Rybár, Rafael
|4 aut
|9 1388078
|
| 700 |
1 |
|
|a Vargová, Viola,
|d 1977-
|4 aut
|9 224069
|
| 711 |
1 |
|
|a Alpe Adria Cardiology Meeting
|n (13. :
|d 2005 :
|c Piešťany, Slovensko)
|4 aut
|9 218287
|
| 773 |
0 |
|
|t Kardiológia
|g Vol. 14, no. 3 (2005), p. K/C 103
|x 1210-0048
|
| 850 |
|
|
|a Slovenská národná knižnica
|
| 852 |
|
|
|a Slovenská národná knižnica
|
| 958 |
|
|
|a article27
|
| 958 |
|
|
|a OND
|
| 999 |
|
|
|c 2938513
|d 2940443
|
